Protective effect of O6-methylguanine-DNA-methyltransferase on mammalian cells

Chinese Medical Journal

Volumn 120, Issue 8, 2007, Pages 714-717

  Li, Dong Bo ^a   Wang, Ji Shi ^a   Fang, Qin ^a   Sun, Hai Yang ^a   Xu, Wei ^a   Li, Wei Da ^a  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Drug resistance; Gene therapy; O6 methylguanine DNA methyltransferase; Transfection

Indexed keywords

LIPOSOME; MESSENGER RNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; CHLORMETHINE DERIVATIVE; GREEN FLUORESCENT PROTEIN; NITROCAPHANE;

ARTICLE; CANCER GENE THERAPY; CELL BASED GENE THERAPY; CELL PROTECTION; CELL STRAIN K 562; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SENSITIVITY; EUKARYOTIC CELL; EXPRESSION VECTOR; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; LIPOSOMAL GENE DELIVERY SYSTEM; LIVER CELL; MAMMAL CELL; MOLECULAR CLONING; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MONONUCLEAR CELL; PHYSIOLOGY;

BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GREEN FLUORESCENT PROTEINS; HEPATOCYTES; HUMANS; K562 CELLS; LEUKOCYTES, MONONUCLEAR; MICROSCOPY, FLUORESCENCE; NITROGEN MUSTARD COMPOUNDS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 34248680526     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200704020-00019     Document Type: Article

References (20)

1. Balicki D, Beutler E. Gene therapy of human disease. Medicine 2002; 81: 69-86.
2. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002; 30: e36.
3. Dave UP, Jenkins NA, Copeland NG. Gene therapy insertional mutagenesis insights. Science 2004; 303: 333-336.
4. Buchsbaum DJ, Curiel DT. Gene therapy for the treatment of cancer. Cancer Biother Radiopharm 2001; 16: 275-288.
5. Kiem HP, Sellers S, Thomasson B, Morris JC, Tisdale JF, Horn PA, et al. Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia. Mol Ther 2004; 9: 389-395.
6. Gerson SL. MGMT: its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer J 2004; 4: 296-307.
7. Costello JF, Plass C. Methylation matters. J Med Genet 2001; 38: 285-303.
8. Gerson SL. Clinical relevance of MGMT in the treatment of cancer. J Clin Oncol 2002; 20: 2388-2399.
9. Nakatsu Y, Hattori K, Hayakawa H, Shimizu K, Sekiguchi M. Organization and expression of the human gene for O6-methylguanine-DNA-methyltransferase. Mutat Res 1993; 293: 119-132.
10. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000; 343: 1350-1354.
11. 6-methylguanine-DNA-methyltransferase gene messenger RNA in gliomas by means of real-time RT-PCR and clinical response to nitrosoureas. Cell Mol Neurobiol 2005; 25: 1067-1071.
12. Vielhauer V, Sarafoff M, Gais P, Rabes HM. Cell type-specific induction of O6-alkylguanine-DNA alkyltransferase mRNA expression in rat liver during regeneration, inflammation and preneoplasia. J Cancer Res Clin Oncol 2001; 127: 591-602.
13. Boley SE, McManus TP, Maher VM, McCormick JJ. Malignant transformation of human fibroblast cell stain MSU-1.1 by N-methyl-N-nitrosourea: evidence of elimination of p53 by homologous recombination. Cancer Res 2000; 60: 4105-4111.
14. + cells. Leuk Res 2002; 26: 281-288.
15. Neff T, Beard BC, Peterson LJ, Anandakumar P, Thompson J, Kiem HP. Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy. Blood 2005; 105: 997-1002.
16. Richard E, Robert E, Cario-Andre M, Ged C, Geronimi F, Gerson SL, et al. Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selection. Gene Ther 2004; 11: 1638-1647.
17. Christmann M, Pick M, Lage H, Schadendorf D, Kaina B. Acquired resistance of melanoma cells to the antineoplastic agent fotemustine is cuased by reactivation of the DNA repair gene MGMT. Int J Cancer 2001; 92: 123-129.
18. 6-alkylguanine-DNA alkyltransferase. Mol Cancer Ther 2004; 3: 1215-1220.
19. 6-alkylguanine-DNA alkyltransferase activity in peripheral blood mononuclear cells. Carcinogenesis 2005; 26: 1473-1480.
20. 6-(4-bromothenyl) guanine reverses temozolomide resistance in human breast tumour MCF-7 cells and xenografts. Br J Cancer 2005; 93: 1152-1156.